Allergy Desensitization Shots: The Clinical Term for SCIT
Allergy desensitization shots is the historical clinical term for subcutaneous immunotherapy (SCIT) — the same 3-to-5-year allergen-extract injection course defined in Cox 2011 PP3. Cochrane 2007 meta-analysis of 51 RCTs found symptom SMD -0.73 and medication SMD -0.57. The term shifted to 'immunotherapy' around 2010 to reduce confusion with acute drug-desensitization protocols. Treatment provides durable post-discontinuation remission per Durham 1999 NEJM.
8 peer-reviewed sources
Allergy desensitization shots are the older clinical name for subcutaneous immunotherapy (SCIT) — the same 3-to-5-year escalating allergen-extract injection course used today, with no change in procedure or evidence base.
The essentials
Allergy desensitization shots is the clinical term used from Leonard Noon's first grass-pollen injections (Lancet 1911;1:1572-1573) through most of the twentieth century to describe what US specialty practice now calls subcutaneous immunotherapy (SCIT). The Cox 2011 Practice Parameter Third Update (JACI 2011;127[1 Suppl]:S1-S55, DOI 10.1016/j.jaci.2010.09.034) adopted 'subcutaneous immunotherapy' as the operative term; 'desensitization' and its synonym 'hyposensitization' remain in use in European literature and among clinicians trained before the 2010 nomenclature shift.
The reason for the terminology change matters practically. In modern allergy practice, 'desensitization' has a second meaning: acute drug-desensitization protocols for penicillin allergy, chemotherapy hypersensitivity, or aspirin hypersensitivity, where patients receive escalating doses of a culprit medication over hours to days to enable a single critical course of treatment. This is a completely different inpatient procedure that does not produce durable tolerance and must be redone if the drug is needed again. By reserving 'immunotherapy' for the chronic aeroallergen procedure, clinicians reduce the chance of a patient confusing a multi-year tolerance-induction course with a one-time drug-desensitization protocol.
The underlying mechanism the older term refers to is real and unchanged. SCIT — formerly called desensitization — works by injecting escalating doses of allergen-specific extracts subcutaneously, shifting immune responses from Th2-driven allergy toward regulatory T-cell-mediated tolerance. Allergen-specific IgG4 blocking antibodies rise 10- to 100-fold, competing with IgE for allergen binding. FOXP3+ regulatory T cells expand and suppress the Th2 cytokine cascade (IL-4, IL-5, IL-13). Over the 3-to-5-year course, mast-cell and eosinophil populations fall in target tissues.
Before committing to any desensitization (immunotherapy) course, identifying which specific allergens drive a patient's symptoms is the essential first step. Curex pairs at-home IgE testing with board-certified allergist review to identify which specific allergens drive symptoms — the same component-resolved diagnostic workup that precedes any desensitization decision under Cox 2011 protocol.
Patients who type 'allergy desensitization shots' are typically older adults treated in a previous decade, patients referred by a clinician trained before 2010, or patients who encountered the term in a health reference written before the nomenclature shift. For all of them, the procedure they are looking for is exactly what their allergist today calls SCIT — same extracts, same 3-to-5-year course, same Cox 2011 protocol.
How allergy shots retrain your immune system
The mechanism behind allergy desensitization shots is a shift from Th2-driven allergic inflammation to regulatory T-cell-mediated tolerance. Allergen-specific FOXP3+ Treg cells expand under repeated controlled allergen exposure, producing IL-10 and TGF-beta that suppress the Th2 cytokine cascade. Simultaneously, B cells undergo class-switching from IgE to IgG4, producing blocking antibodies that out-compete IgE for allergen binding at mast cell surfaces. These changes accumulate over the 3-to-5-year course; shorter courses are associated with higher relapse rates, which is why Cox 2011 PP3 specifies a minimum of 3 years.
Diagnostic confirmation of IgE sensitization
Skin prick testing or specific-IgE blood testing confirms which allergens are driving symptoms. Only allergens with documented IgE sensitization and corresponding symptoms are included in the extract mixture — this is why testing precedes every desensitization course.
Build-up phase: escalating doses over 4-6 months
Injections begin at 1,000- to 10,000-fold below the maintenance dose and increase 1-2 times per week for approximately 26-28 visits. A mandatory 30-minute post-injection observation period is required at every visit — approximately 85% of systemic reactions occur within this window.
Maintenance phase: sustained dosing for 3-5 years
Once the therapeutic maintenance dose is reached, injections continue every 2-4 weeks for 3-5 years total. The immune system consolidates tolerance during this phase. Gaps greater than 3-4 months in maintenance typically require restarting the course.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Efficacy by allergen — what the data shows
The evidence base for allergy desensitization shots is among the strongest in clinical allergology. Calderón MA et al (Cochrane Database Syst Rev 2007, DOI 10.1002/14651858.CD001936.pub2) analyzed 51 RCTs with 2,871 patients and found a pooled symptom-score SMD of -0.73 (95% CI -0.97 to -0.50) and medication-score SMD of -0.57 (95% CI -0.82 to -0.33) in favor of SCIT versus placebo. Durham SR et al (NEJM 1999) showed that a 3-year grass pollen course produced 4 additional years of post-discontinuation remission — the key clinical advantage of desensitization versus ongoing pharmacotherapy.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
Allergy desensitization shots (SCIT) occupy a unique position in the treatment spectrum because they are the only intervention that modifies the underlying immune dysfunction rather than just suppressing downstream symptoms. The Cox/Murphey/Hankin 2020 review (Immunol Allergy Clin North Am 2020;40[1]:69-85, PMID 31761122) explicitly classifies SCIT as the only disease-modifying allergy therapy with long-term remission documented in randomized trials.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
At-Home Allergy Shots (Curex SCIT) | |||||
SLIT drops (sublingual) | |||||
Antihistamines + nasal steroids |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
For patients who want to skip the 39-visit Year 1 clinic schedule without giving up shots, Curex delivers the same SCIT desensitization course as one weekly injection you give yourself at home for $129/month — a personalized serum sterile-compounded to USP <797>, prescribed by a board-certified allergist, with your first dose and every dose change supervised live over Zoom and a prescribed epinephrine auto-injector confirmed on hand.
See if at-home shots are right for youFrequently asked questions
Are allergy desensitization shots the same as allergy shots?
Yes. Allergy desensitization shots and allergy shots (subcutaneous immunotherapy, SCIT) are identical procedures. 'Desensitization' was the dominant clinical term from Noon's first grass-pollen injections in 1911 through most of the twentieth century. US specialty practice shifted to 'immunotherapy' around 2010, partly to reduce confusion with acute drug-desensitization protocols used for penicillin or chemotherapy hypersensitivity — a completely different, shorter inpatient procedure. The underlying procedure, extracts, dosing protocol, and evidence base are identical regardless of which name is used.
How long does allergy desensitization take?
Allergy desensitization via SCIT requires a 3-to-5-year course per the Cox 2011 Practice Parameter Third Update. The build-up phase spans approximately 4-6 months with 1-2 weekly injections (roughly 26-28 visits). The maintenance phase then continues every 2-4 weeks for the remaining 3-5 years. In Year 1, patients typically make approximately 39 total clinic visits. Shorter courses are associated with higher relapse rates, which is why the 3-year minimum is recommended. Most patients notice meaningful symptom improvement within the first year of reaching maintenance.
Is drug desensitization the same as allergy desensitization shots?
No. Allergy desensitization shots (SCIT) are a multi-year course of subcutaneous allergen extract injections that induce durable allergen-specific tolerance through regulatory T cells and blocking IgG4 antibodies. Acute drug desensitization is a different inpatient procedure used to allow a patient to tolerate a critical medication — such as penicillin or a chemotherapy agent — to which they are hypersensitive. Drug desensitization is typically completed over hours to days, does not produce durable tolerance, and must be repeated if the drug is needed again in the future. The two procedures share a name but are clinically unrelated.
What is the success rate for allergy desensitization shots?
Cochrane meta-analysis by Calderón MA et al (2007, 51 RCTs, 2,871 patients) found a pooled symptom-score standardized mean difference of -0.73 and medication-score SMD of -0.57 in favor of SCIT versus placebo for seasonal allergic rhinitis. Individual allergen efficacy varies: grass pollen and ragweed show approximately 80-85% symptom reduction in landmark RCTs; cat dander approximately 70-72%; dust mite approximately 80%. Real-world completion matters — Tkacz et al (2021, MarketScan n=103,207) found only 43.9% of patients reached the maintenance phase, making adherence the dominant variable in actual outcomes.
Are allergy desensitization shots safe?
Allergy desensitization shots were traditionally administered in a physician's office because of the small but real risk of systemic allergic reactions. Local injection-site reactions (redness, swelling, itching) occur in approximately 20-70% of patients and are expected. Systemic reactions occur in approximately 0.1% of injection visits per Epstein TG et al (Ann Allergy Asthma Immunol 2013/2014). Fatal reactions are extremely rare — one fatality per 23.3 million injection visits in the 2008-2012 surveillance period. Approximately 85% of systemic reactions occur within 30 minutes of the injection, which is why a post-injection observation matters — and why at-home programs like Curex's confirm a prescribed epinephrine auto-injector on hand, supervise the first dose and every dose change live over Zoom, and keep an allergist overseeing the plan, making safe self-administration possible for eligible maintenance patients.
Do allergy desensitization shots produce permanent relief?
Allergy desensitization shots produce durable but not permanent relief. Durham SR et al (NEJM 1999;341:468-475) showed that patients who completed a 3-year grass-pollen SCIT course maintained symptom scores comparable to ongoing-treatment patients for at least 4 years after discontinuation. Observational follow-up suggests 7-12 years of durable benefit for many patients. A subset of patients eventually re-sensitize and may need a repeat course. No clinician should promise 'permanent' relief, but the 3-to-5-year course represents the only intervention with documented post-discontinuation remission in randomized trials.
Can children receive allergy desensitization shots?
Yes. The Cox 2011 Practice Parameter Third Update supports SCIT in children aged 5 years and older, noting that young age is not a contraindication in the absence of other risk factors. The Preventive Allergy Treatment (PAT) study, with 10-year follow-up published by Jacobsen L et al (Allergy 2007;62:943-948), found that a 3-year pollen SCIT course in children with allergic rhinitis reduced the subsequent development of asthma by approximately half compared to controls — an effect not produced by any pharmacotherapy. This asthma-prevention benefit is considered one of the strongest arguments for early initiation.
Related Articles
Names of Allergy Shots for Adults | Curex Guide
The clinical name is SCIT. Extracts come from Greer, ALK-Abelló, or Stallergenes Greer. FDA-approved branded tablets: Grastek, Oralair, Ragwitek, Odactra.
Read moreCat Allergy Shot for Humans | Curex SCIT Guide
This page covers cat allergy shots FOR HUMANS — SCIT with FDA-standardized Fel d 1 extract (10,000 BAU/mL). Not Cytopoint. Not Apoquel. ~72% symptom reduction in RCTs.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreAllergy Test Shots vs Treatment: CPT Codes | Curex
Allergy test shots (CPT 95004 prick, CPT 95024 intradermal) diagnose sensitization in one visit. Treatment shots (SCIT, CPT 95115/95117) are a 3-5 year immunotherapy course.
Read moreAllergy Injection Sites – Where SCIT Shots Are Given
SCIT injections go subcutaneously in the posterior lateral upper arm. Sites, alternating-arm protocol, and dose-reduction rules for large local reactions.
Read moreAllergy Shot Therapy: SCIT as Disease-Modifying Care | Curex
Allergy shot therapy (SCIT) is the only disease-modifying allergy therapy per Cox/Murphey/Hankin 2020. Cochrane 2007: symptom SMD -0.73 across 51 RCTs. Learn the course.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.